Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
While numerous microRNAs (miRNAs) have been reported to alter their expression levels in human lung cancer tissues compared with normal tissues, the function of these miRNAs and their contribution to the long process of lung cancer development remains largely unknown. We applied a tobacco-specific carcinogen-induced cancer model to investigate the involvement of miRNAs in early lung cancer development, which could also provide information on potential, early biomarkers of lung cancers. Male F344 rats were first chronically treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a carcinogen present in tobacco products, for up to 20 weeks. The expression profiles of miRNAs in rat lungs were then determined. As measured by miRNA microarrays and confirmed by Northern blot and real-time polymerase chain reaction analyses, NNK treatment reduced the expression of a number of miRNAs, such as miR-101, miR-126*, miR-199 and miR-34. Significantly, these miRNAs overlap with previously published reports on altered miRNA expression in human lung cancer samples. These miRNAs might, therefore, represent early-response miRNAs that signify the molecular changes associated with pulmonary tumorigenesis. Moreover, we identified cytochrome P450 (CYP) 2A3, a critical enzyme in rat lungs that activates NNK to render it carcinogenic, as a potential target of miR-126*. NNK treatment in rats repressed miR-126* but induced CYP2A3 expression, a mechanism that may potentiate the oncogenic effects of NNK.
Kalscheuer
Stephen
S
Department of Pharmacology, University of Minnesota, Minneapolis, MN 55455, USA.
Zhang
Xiaoxiao
X
Zeng
Yan
Y
Upadhyaya
Pramod
P
D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases / Q000187:drug effects / Q000378:metabolism; D015152:Blotting, Northern; D015153:Blotting, Western; D002273:Carcinogens / Q000633:toxicity*; D002471:Cell Transformation, Neoplastic / Q000187:drug effects / Q000235:genetics*; D015870:Gene Expression / Q000187:drug effects; D020869:Gene Expression Profiling; D008175:Lung Neoplasms / Q000139:chemically induced* / Q000235:genetics*; D008297:Male; D035683:MicroRNAs / Q000187:drug effects* / Q000235:genetics; D009602:Nitrosamines / Q000633:toxicity*; D020411:Oligonucleotide Array Sequence Analysis; D051381:Rats; D011916:Rats, Inbred F344; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013250:Steroid Hydroxylases / Q000187:drug effects / Q000378:metabolism; D014026:Nicotiana / Q000737:chemistry
D002273:Carcinogens; D035683:MicroRNAs; D009602:Nitrosamines; C016583:4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; D013250:Steroid Hydroxylases; D001189:Aryl Hydrocarbon Hydroxylases; C029009:steroid hormone 7-alpha-hydroxylase
Nature. 2005 Feb 17;433(7027):769-73
15685193
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9779-84
12902540
Curr Opin Genet Dev. 2006 Apr;16(2):203-8
16503132
Mol Cell. 2002 Jun;9(6):1327-33
12086629
Cancer Res. 2007 Sep 15;67(18):8433-8
17823410
Cancer Surv. 1989;8(2):459-73
2696590
Cancer Res. 2004 Jun 1;64(11):3753-6
15172979
Cell Cycle. 2007 Jul 1;6(13):1586-93
17554199
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
15761078
Semin Surg Oncol. 2003;21(3):164-75
14508849
Eur J Cancer Prev. 1996 Sep;5 Suppl 1:7-10
8972286
Nature. 2007 Jun 28;447(7148):1130-4
17554337
Carcinogenesis. 1988 Jun;9(6):875-84
3286030
Eur J Cancer Prev. 1996 Sep;5 Suppl 1:33-8
8972290
Carcinogenesis. 1983;4(3):305-10
6339096
Chem Res Toxicol. 2005 Feb;18(2):95-110
15720112
Cancer Cell. 2006 Mar;9(3):189-98
16530703
Nucleic Acids Res. 2004 Sep 08;32(16):4776-85
15356295
Cell. 2005 Mar 11;120(5):635-47
15766527
Development. 2005 Nov;132(21):4645-52
16224044
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61
16461460
Oncogene. 2006 Oct 9;25(46):6163-9
17028595
Mol Cell. 2007 Jun 8;26(5):745-52
17540599
IARC Monogr Eval Carcinog Risks Hum. 2004;83:1-1438
15285078
Eur J Cancer Prev. 1996 Sep;5 Suppl 1:11-7
8972287
Chem Res Toxicol. 2007 Feb;20(2):235-45
17305407
Genes Dev. 2006 Mar 1;20(5):515-24
16510870
MMWR Morb Mortal Wkly Rep. 2007 Nov 9;56(44):1157-61
17989644
Cancer Res. 1988 Dec 1;48(23):6912-7
3180100
Mol Cell. 2007 Jun 8;26(5):731-43
17540598
Chem Res Toxicol. 1998 Jun;11(6):559-603
9625726
Curr Biol. 2007 Aug 7;17(15):1298-307
17656095
Nat Methods. 2004 Oct;1(1):47-53
15782152
Nature. 2004 Sep 16;431(7006):350-5
15372042
Public Health Rep. 2001 Jul-Aug;116(4):336-43
12037262
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D140-4
16381832
Cell. 2004 Jan 23;116(2):281-97
14744438
Cell. 2005 Aug 26;122(4):553-63
16122423